Hartmann’s Solution for Infusion, PPC PSEB bag Ireland - English - HPRA (Health Products Regulatory Authority)

hartmann’s solution for infusion, ppc pseb bag

fresenius kabi limited - sodium chloride; potassium chloride; calcium chloride dihydrate ; sodium lactate solution 50% - solution for infusion - percent volume/volume - solutions affecting the electrolyte balance; electrolytes

VOLUVEN 10 Per Cent Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

voluven 10 per cent solution for infusion

fresenius kabi limited - poly-(0-2-hydroxyethyl)starch (130/0.4), sodium chloride - solution for infusion - 10 per cent - blood substitutes and plasma protein fractions

VOLUVEN 10 Per Cent Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

voluven 10 per cent solution for infusion

fresenius kabi limited - poly-(0-2-hydroxyethyl)starch (130/0.4), sodium chloride - solution for infusion - 10 per cent - blood substitutes and plasma protein fractions

Glucose 5% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose 5% w/v solution for infusion

fresenius kabi limited - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates

Volulyte 6% solution for infusion Malta - English - Medicines Authority

volulyte 6% solution for infusion

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - poly, hydroxyethyl, starch, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium chloride - solution for infusion - sodium acetate trihydrate 4.63 g sodium chloride 6.02 g magnesium chloride hexahydrate 0.3 g poly(o-2-hydroxyethyl)starch 60 g potassium chloride 0.3 g - blood substitutes and perfusion solutions

Voluven New Zealand - English - Medsafe (Medicines Safety Authority)

voluven

fresenius kabi new zealand limited - hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons); sodium chloride 0.9%; hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) - solution for infusion - active: hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) sodium chloride 0.9% excipient: hydrochloric acid sodium hydroxide water for injection active: hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - treatment of hypovolaemia due to acute blood loss when chrystlloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

VOLUVEN 6 %w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

voluven 6 %w/v solution for infusion

fresenius kabi limited - poly(o-2-hydroxyethyl)starch, sodium chloride - solution for infusion - 6 %w/v - blood substitutes and plasma protein fractions

VOLUVEN 6 %w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

voluven 6 %w/v solution for infusion

fresenius kabi limited - poly(o-2-hydroxyethyl)starch, sodium chloride - solution for infusion - 6 %w/v - blood substitutes and plasma protein fractions

VOLUVEN 6% %w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

voluven 6% %w/v solution for infusion

fresenius kabi limited - poly(o-2-hydroxyethyl)starch, sodium chloride - solution for infusion - 6% %w/v - blood substitutes and plasma protein fractions

VOLUVEN Israel - English - Ministry of Health

voluven

cure medical & technical supply - sodium chloride; starch etherified - solution for infusion - starch etherified 60 g/l; sodium chloride 9 g/l - blood substitutes and plasma protein fractions - therapy and prophylaxis of hypovolemia, acute normovolaemic haemodilution technique.